Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
11:40am, Thursday, 21'st Aug 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Novo To Contact Him Directly To Discuss Their Options If you suffe
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO). Such in
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Aug 2025)
11:05am, Thursday, 21'st Aug 2025
Among all the weight loss drugs, Ozempic has become a phenomenon. With as much as $17 billion in sales in 2024 and over $10 billion in the first half of 2025, it shows no signs of slowing down, much t
Fat busters having a muted impact consumer sector. But for how long?
09:52am, Thursday, 21'st Aug 2025
Fine dining under pressure, beer sales at risk, and snack makers bracing for a shake-up. The rise of GLP-1 weight-loss drugs is starting to ripple through the consumer economy.
Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
08:45am, Thursday, 21'st Aug 2025
NEW YORK , Aug. 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class perio
Novo Nordisk Freezes Hiring in Noncritical Areas
02:07am, Thursday, 21'st Aug 2025
The pharma giant has almost doubled the size of its workforce over the last five years but is now looking to tighten cost controls amid challenges in the obesity-drug market.
Riding high on Wegovy, Novo doubled its workforce. Now layoffs loom
02:06am, Thursday, 21'st Aug 2025
As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that almost doubled staff
Navigating The Novo Nordisk Case With The Inversion Mental Model
06:29pm, Wednesday, 20'th Aug 2025
In this article I'll use Charlie Munger's inversion model to analyze Novo Nordisk's potential failure points. We'll go over the recent market share loss, supply chain issues, their R&D pipeline, and t
NVO STOCK: Robbins LLP Reminds NVO Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Novo Nordisk A/S
05:35pm, Wednesday, 20'th Aug 2025
SAN DIEGO , Aug. 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Novo Nordisk A/S (NYSE: NVO) securi
DEADLINE ALERT for SOC, LMT, NVO, and LINE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
12:07pm, Wednesday, 20'th Aug 2025
LOS ANGELES, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded
Novo Nordisk halts hiring as new CEO's restructuring continues
10:37am, Wednesday, 20'th Aug 2025
Novo Nordisk has initiated a hiring freeze as it looks to control costs under new boss Maziar Mike Doustdar. All markets and departments, apart from business-critical roles, will be affected by the p
Bagsværd, Denmark, 20 August 2025 – Novo Nordisk today announced new data showing the cardiovascular protective benefits of Wegovy ® and Ozempic ® will be presented at the European Society of Car
Novo Nordisk: Cleared For A Climb
08:41am, Wednesday, 20'th Aug 2025
Novo Nordisk is a sector leader in the fast-growing GLP-1 market, boasting strong fundamentals, a healthy balance sheet, and solid management. Recent stock weakness stems from sector-wide regulatory f
1 Reason to Buy NVO
06:15am, Wednesday, 20'th Aug 2025
It's one thing for a pharmaceutical company to have a blockbuster drug in its portfolio. It's quite another if such a product can be successfully extended to win approvals for other indications.
Drugmaker Novo Nordisk enacts worldwide hiring freeze for non-critical job roles
05:35am, Wednesday, 20'th Aug 2025
Wegovy-maker Novo Nordisk has implemented a global hiring freeze, which covers job roles that are not critical for its business, the company said on Wednesday.
